Suppr超能文献

血清25-羟维生素D作为非糖尿病透析前慢性肾脏病患者1-84甲状旁腺激素和骨密度的独立决定因素。

Serum 25-hydroxyvitamin D as an independent determinant of 1-84 PTH and bone mineral density in non-diabetic predialysis CKD patients.

作者信息

Tomida Kodo, Hamano Takayuki, Mikami Satoshi, Fujii Naohiko, Okada Noriyuki, Matsui Isao, Nagasawa Yasuyuki, Moriyama Toshiki, Ito Takahito, Imai Enyu, Isaka Yoshitaka, Rakugi Hiromi

机构信息

Department of Geriatric Medicine and Nephrology, Osaka University Graduate School of Medicine, Box B6, 2-2 Yamada-oka, Suita, Osaka 565-0871, Japan.

出版信息

Bone. 2009 Apr;44(4):678-83. doi: 10.1016/j.bone.2008.11.016. Epub 2008 Dec 9.

Abstract

The role of 25-hydroxyvitamin D [25(OH)D] and fibroblast growth factor-23 (FGF-23) in chronic kidney disease-mineral and bone disorder (CKD-MBD) remains elusive in predialysis CKD patients. From the fact that FGF-23 suppresses bone mineralization in vitro and that 1alpha-hydroxylase is present in parathyroid cells and osteoblasts, they may be associated with bone mass or serum parathyroid hormone (PTH) level. In this cross-sectional observational study, we investigated the potential associations of 25(OH)D or FGF-23 with 1-84 PTH and bone mineral density (BMD) in the femoral neck (FN) and lumbar spine (LS) of 325 non-diabetic patients. All patients had stages 3-5 CKD and had never been treated with bisphosphonate, estrogen, or vitamin D. We measured bone-specific alkaline phosphatase (bone ALP), intact FGF-23 and 1-84 PTH in a third generation assay, and performed a multiple regression analysis for 1-84 PTH and BMD Z-score. In our cohort, 80.1% had 25(OH)D levels less than 30 ng/mL, and 4.1% had levels less than 15 ng/mL. A univariate analysis indicated a negative association for 25(OH)D with 1-84 PTH and bone ALP. A multivariate analysis showed that the significant determinants for 1-84 PTH were 25(OH)D, estimated glomerular filtration rate (eGFR), corrected calcium, serum calcitriol and phosphate. Intriguingly, the three former parameters had negative associations with 1-84 PTH while calcitriol had a positive association. While further adjustment of FGF-23 extinguished the positive association of phosphate and 1-84 PTH, there was absolutely no increase in the R2. With regard to the BMD Z-score, 25(OH)D and the body mass index were the significant common independent positive determinants for both FN and LS, whereas bone ALP was the negative determinant even though there was no correlation noted for 1-84 PTH, calcitriol, or FGF-23 with BMD. In addition, eGFR positively contributed to the Z-score only in FN. Therefore, despite a positive correlation between 25(OH)D and calcitriol, their contribution to the CKD-MBD appears to be different. Since the significant associations for 25(OH)D with 1-84 PTH and BMD were independent of serum calcitriol and bone ALP, this might imply that 25(OH)D has a direct effect on the parathyroid gland and bone.

摘要

在未进行透析的慢性肾脏病(CKD)患者中,25-羟维生素D [25(OH)D]和成纤维细胞生长因子23(FGF-23)在慢性肾脏病-矿物质和骨异常(CKD-MBD)中的作用仍不明确。鉴于FGF-23在体外可抑制骨矿化,且甲状旁腺细胞和成骨细胞中存在1α-羟化酶,它们可能与骨量或血清甲状旁腺激素(PTH)水平有关。在这项横断面观察性研究中,我们调查了325例非糖尿病患者的25(OH)D或FGF-23与1-84 PTH以及股骨颈(FN)和腰椎(LS)骨密度(BMD)之间的潜在关联。所有患者均处于3-5期CKD,且从未接受过双膦酸盐、雌激素或维生素D治疗。我们采用第三代检测方法测量了骨特异性碱性磷酸酶(骨ALP)、完整FGF-23和1-84 PTH,并对1-84 PTH和BMD Z评分进行了多元回归分析。在我们的队列中,80.1%的患者25(OH)D水平低于30 ng/mL,4.1%的患者水平低于15 ng/mL。单因素分析表明25(OH)D与1-84 PTH和骨ALP呈负相关。多因素分析显示,1-84 PTH的显著决定因素为25(OH)D、估计肾小球滤过率(eGFR)、校正钙、血清骨化三醇和磷酸盐。有趣的是,前三个参数与1-84 PTH呈负相关,而骨化三醇呈正相关。虽然进一步调整FGF-23消除了磷酸盐与1-84 PTH的正相关,但R2并没有增加。关于BMD Z评分,25(OH)D和体重指数是FN和LS的显著共同独立正决定因素,而骨ALP是负决定因素,尽管未发现1-84 PTH、骨化三醇或FGF-23与BMD之间存在相关性。此外,eGFR仅对FN的Z评分有正向贡献。因此,尽管25(OH)D与骨化三醇之间存在正相关,但它们对CKD-MBD的作用似乎不同。由于25(OH)D与1-84 PTH和BMD的显著关联独立于血清骨化三醇和骨ALP,这可能意味着25(OH)D对甲状旁腺和骨骼有直接作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验